Home/Filings/4/0001847903-23-000043
4//SEC Filing

CHAO DAVID M 4

Accession 0001847903-23-000043

CIK 0001847903other

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 5:05 PM ET

Size

7.6 KB

Accession

0001847903-23-000043

Insider Transaction Report

Form 4
Period: 2023-02-01
CHAO DAVID M
Chief Administrative Officer
Transactions
  • Award

    Ordinary Shares

    2023-02-01+77,200293,600 total
  • Award

    Share Option (right to buy)

    2023-02-01+115,000115,000 total
    Exercise: $3.85Exp: 2033-02-01Ordinary Shares (115,000 underlying)
Footnotes (3)
  • [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  • [F2]The shares reported in this transaction represent Restricted Share Units ("RSUs") issued under the Centessa Pharmaceuticals plc Amended and Restated 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one Ordinary Share of the Issuer. The RSUs shall vest and be settled in four equal annual installments with the first such annual vesting being on February 1, 2024.
  • [F3]1/48th of the shares subject to such option shall vest and become exercisable in equal monthly installments with the first installment vesting on March 1, 2023.

Issuer

Centessa Pharmaceuticals plc

CIK 0001847903

Entity typeother

Related Parties

1
  • filerCIK 0001861871

Filing Metadata

Form type
4
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 5:05 PM ET
Size
7.6 KB